Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin
- DOI
- 10.1186/s13063-022-06473-9
- Published
- 2022-07-08
- Container
- Trials
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13063-022-06473-9,
title = {Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin},
author = {Roch Christian Johnson and Emma Sáez-López and Esaï Sèdjro Anagonou and Godwin Gérard Kpoton and Adjimon Gilbert Ayelo and Ronald Sètondji Gnimavo and Franck Zinsou Mignanwande and Jean-Gabin Houezo and Ghislain Emmanuel Sopoh and Juliet Addo and Lindsay Orford and Georgios Vlasakakis and Nandita Biswas and Felix Calderon and Oscar Della Pasqua and Anna Gine-March and Zaida Herrador and Alfonso Mendoza-Losana and Gabriel Díez and Israel Cruz and Santiago Ramón-García},
year = {2022},
journal = {Trials},
doi = {10.1186/s13063-022-06473-9},
url = {https://doi.org/10.1186/s13063-022-06473-9}
}RIS
TY - JOUR TI - Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin AU - Roch Christian Johnson AU - Emma Sáez-López AU - Esaï Sèdjro Anagonou AU - Godwin Gérard Kpoton AU - Adjimon Gilbert Ayelo AU - Ronald Sètondji Gnimavo AU - Franck Zinsou Mignanwande AU - Jean-Gabin Houezo AU - Ghislain Emmanuel Sopoh AU - Juliet Addo AU - Lindsay Orford AU - Georgios Vlasakakis AU - Nandita Biswas AU - Felix Calderon AU - Oscar Della Pasqua AU - Anna Gine-March AU - Zaida Herrador AU - Alfonso Mendoza-Losana AU - Gabriel Díez AU - Israel Cruz AU - Santiago Ramón-García PY - 2022 JO - Trials DO - 10.1186/s13063-022-06473-9 UR - https://doi.org/10.1186/s13063-022-06473-9 ER -
APA
Johnson, R. C., Sáez-López, E., Anagonou, E. S., Kpoton, G. G., Ayelo, A. G., Gnimavo, R. S., Mignanwande, F. Z., Houezo, J., Sopoh, G. E., Addo, J., Orford, L., Vlasakakis, G., Biswas, N., Calderon, F., Pasqua, O. D., Gine-March, A., Herrador, Z., Mendoza-Losana, A., Díez, G., Cruz, I., & Ramón-García, S. (2022). Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin. Trials. https://doi.org/10.1186/s13063-022-06473-9
Source records
- crossref · retrieved 2026-09-27T05:40:38.380Z